Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn).

Salmanton-García J, Seidel D, Koehler P, Mellinghoff SC, Herbrecht R, Klimko N, Ráčil Z, Falces-Romero I, Ingram P, Benítez-Peñuela MÁ, Rodríguez JY, Desoubeaux G, Barać A, García-Vidal C, Hoenigl M, Mehta SR, Cheng MP, Klyasova G, Heinz WJ, Iqbal N, Krause R, Ostermann H, Penack O, Schalk E, Sheppard DC, Willinger B, Wisplinghoff H, Vehreschild JJ, Cornely OA, Vehreschild MJGT; FungiScope® ECMM/ISHAM Working Group .

J Antimicrob Chemother. 2019 Aug 8. pii: dkz344. doi: 10.1093/jac/dkz344. [Epub ahead of print]

PMID:
31393591
2.

Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis.

Koehler P, Stecher M, Cornely OA, Koehler D, Vehreschild MJGT, Bohlius J, Wisplinghoff H, Vehreschild JJ.

Clin Microbiol Infect. 2019 Apr 27. pii: S1198-743X(19)30202-2. doi: 10.1016/j.cmi.2019.04.024. [Epub ahead of print] Review.

PMID:
31039444
3.

Mould-reactive T cells for the diagnosis of invasive mould infection-A prospective study.

Steinbach A, Cornely OA, Wisplinghoff H, Schauss AC, Vehreschild JJ, Rybniker J, Hamprecht A, Richter A, Bacher P, Scheffold A, Koehler P.

Mycoses. 2019 Jul;62(7):562-569. doi: 10.1111/myc.12919. Epub 2019 May 23.

PMID:
31034691
4.

Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans.

Bacher P, Hohnstein T, Beerbaum E, Röcker M, Blango MG, Kaufmann S, Röhmel J, Eschenhagen P, Grehn C, Seidel K, Rickerts V, Lozza L, Stervbo U, Nienen M, Babel N, Milleck J, Assenmacher M, Cornely OA, Ziegler M, Wisplinghoff H, Heine G, Worm M, Siegmund B, Maul J, Creutz P, Tabeling C, Ruwwe-Glösenkamp C, Sander LE, Knosalla C, Brunke S, Hube B, Kniemeyer O, Brakhage AA, Schwarz C, Scheffold A.

Cell. 2019 Mar 7;176(6):1340-1355.e15. doi: 10.1016/j.cell.2019.01.041. Epub 2019 Feb 21.

PMID:
30799037
5.

Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope®.

Seidel D, Meißner A, Lackner M, Piepenbrock E, Salmanton-García J, Stecher M, Mellinghoff S, Hamprecht A, Durán Graeff L, Köhler P, Cheng MP, Denis J, Chedotal I, Chander J, Pakstis DL, Los-Arcos I, Slavin M, Montagna MT, Caggiano G, Mares M, Trauth J, Aurbach U, Vehreschild MJGT, Vehreschild JJ, Duarte RF, Herbrecht R, Wisplinghoff H, Cornely OA.

Crit Rev Microbiol. 2019 Feb;45(1):1-21. doi: 10.1080/1040841X.2018.1514366. Epub 2019 Jan 10. Erratum in: Crit Rev Microbiol. 2019 Feb 18;:1.

PMID:
30628529
6.

Fecal microbiota transplantation in a kidney transplant recipient with recurrent urinary tract infection.

Biehl LM, Cruz Aguilar R, Farowski F, Hahn W, Nowag A, Wisplinghoff H, Vehreschild MJGT.

Infection. 2018 Dec;46(6):871-874. doi: 10.1007/s15010-018-1190-9. Epub 2018 Aug 14.

PMID:
30109576
7.

Candida-Reactive T Cells for the Diagnosis of Invasive Candida Infection-A Prospective Pilot Study.

Koehler FC, Cornely OA, Wisplinghoff H, Schauss AC, Salmanton-Garcia J, Ostermann H, Ziegler M, Bacher P, Scheffold A, Alex R, Richter A, Koehler P.

Front Microbiol. 2018 Jun 22;9:1381. doi: 10.3389/fmicb.2018.01381. eCollection 2018.

8.

Analyzing candidemia guideline adherence identifies opportunities for antifungal stewardship.

Mellinghoff SC, Hartmann P, Cornely FB, Knauth L, Köhler F, Köhler P, Krause C, Kronenberg C, Kranz SL, Menon V, Müller H, Naendrup JH, Pützfeld S, Ronge A, Rutz J, Seidel D, Wisplinghoff H, Cornely OA.

Eur J Clin Microbiol Infect Dis. 2018 Aug;37(8):1563-1571. doi: 10.1007/s10096-018-3285-8. Epub 2018 Jun 13.

PMID:
29948362
9.

Impact of choice, timing, sequence and combination of broad-spectrum antibiotics on the outcome of allogeneic haematopoietic stem cell transplantation.

Farowski F, Bücker V, Vehreschild JJ, Biehl L, Cruz-Aguilar R, Scheid C, Holtick U, Jazmati N, Wisplinghoff H, Cornely OA, Vehreschild MJGT.

Bone Marrow Transplant. 2018 Jan;53(1):52-57. doi: 10.1038/bmt.2017.203. Epub 2017 Nov 13.

PMID:
29131156
10.

Candida-reactive T cells for the diagnosis of invasive Candida infection of the lumbar vertebral spine.

Koehler FC, Cornely OA, Wisplinghoff H, Chang DH, Richter A, Koehler P.

Mycoses. 2018 Jan;61(1):48-52. doi: 10.1111/myc.12696. Epub 2017 Sep 26.

PMID:
28872711
11.

FungiScope -Global Emerging Fungal Infection Registry.

Seidel D, Durán Graeff LA, Vehreschild MJGT, Wisplinghoff H, Ziegler M, Vehreschild JJ, Liss B, Hamprecht A, Köhler P, Racil Z, Klimko N, Sheppard DC, Herbrecht R, Chowdhary A, Cornely OA, FungiScope Group.

Mycoses. 2017 Aug;60(8):508-516. doi: 10.1111/myc.12631.

PMID:
28730644
12.

Establishment of a voluntary electronic Chlamydia trachomatis laboratory surveillance system in Germany, 2008 to 2014.

Dudareva-Vizule S, Haar K, Sailer A, Jansen K, Hamouda O, Wisplinghoff H, Tiemann C, Pape E, Bremer V; Chlamydia trachomatis laboratory sentinel team.

Euro Surveill. 2017 Feb 9;22(6). pii: 30459. doi: 10.2807/1560-7917.ES.2017.22.6.30459.

13.

Invasive infections due to Saprochaete and Geotrichum species: Report of 23 cases from the FungiScope Registry.

Durán Graeff L, Seidel D, Vehreschild MJ, Hamprecht A, Kindo A, Racil Z, Demeter J, De Hoog S, Aurbach U, Ziegler M, Wisplinghoff H, Cornely OA; FungiScope Group.

Mycoses. 2017 Apr;60(4):273-279. doi: 10.1111/myc.12595. Epub 2017 Feb 2.

PMID:
28150341
14.

Determining vancomycin Etest MICs in patients with MRSA bloodstream infection does not support switching antimicrobials.

Hos NJ, Jazmati N, Stefanik D, Hellmich M, AlSael H, Kern WV, Rieg S, Wisplinghoff H, Seifert H, Kaasch AJ.

J Infect. 2017 Mar;74(3):248-259. doi: 10.1016/j.jinf.2016.12.007. Epub 2016 Dec 22.

PMID:
28017826
15.

1,3-β-d-Glucan contamination of common antimicrobials-authors' response.

Liss B, Cornely OA, Hoffmann D, Dimitriou V, Wisplinghoff H.

J Antimicrob Chemother. 2016 Oct;71(10):2997-9. doi: 10.1093/jac/dkw299. Epub 2016 Jul 27. No abstract available.

PMID:
27494926
16.

A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis.

Biehl LM, Vehreschild JJ, Liss B, Franke B, Markiefka B, Persigehl T, Bücker V, Wisplinghoff H, Scheid C, Cornely OA, Vehreschild MJ.

J Antimicrob Chemother. 2016 Sep;71(9):2634-41. doi: 10.1093/jac/dkw199. Epub 2016 Jun 17.

PMID:
27317443
17.

Efficacy of two antiseptic regimens on skin colonization of insertion sites for two different catheter types: a randomized, clinical trial.

Lutz JT, Diener IV, Freiberg K, Zillmann R, Shah-Hosseini K, Seifert H, Berger-Schreck B, Wisplinghoff H.

Infection. 2016 Dec;44(6):707-712. Epub 2016 May 3.

18.

Head-to-Head Comparison of Two Multi-Locus Sequence Typing (MLST) Schemes for Characterization of Acinetobacter baumannii Outbreak and Sporadic Isolates.

Tomaschek F, Higgins PG, Stefanik D, Wisplinghoff H, Seifert H.

PLoS One. 2016 Apr 12;11(4):e0153014. doi: 10.1371/journal.pone.0153014. eCollection 2016.

19.

Prevalence and distribution of Legionella spp in potable water systems in Germany, risk factors associated with contamination, and effectiveness of thermal disinfection.

Kruse EB, Wehner A, Wisplinghoff H.

Am J Infect Control. 2016 Apr 1;44(4):470-4. doi: 10.1016/j.ajic.2015.10.025. Epub 2016 Jan 5.

PMID:
26775932
20.

1,3-β-D-Glucan contamination of common antimicrobials.

Liss B, Cornely OA, Hoffmann D, Dimitriou V, Wisplinghoff H.

J Antimicrob Chemother. 2016 Apr;71(4):913-5. doi: 10.1093/jac/dkv419. Epub 2015 Dec 13.

PMID:
26668235
21.

1,3-ß-D-glucan concentrations in blood products predict false positive post-transfusion results.

Liss B, Cornely OA, Hoffmann D, Dimitriou V, Wisplinghoff H.

Mycoses. 2016 Jan;59(1):39-42. doi: 10.1111/myc.12432. Epub 2015 Nov 18.

PMID:
26576502
22.

Comparative in vitro activity of oral antimicrobial agents against Enterobacteriaceae from patients with community-acquired urinary tract infections in three European countries.

Kresken M, Körber-Irrgang B, Biedenbach DJ, Batista N, Besard V, Cantón R, García-Castillo M, Kalka-Moll W, Pascual A, Schwarz R, Van Meensel B, Wisplinghoff H, Seifert H.

Clin Microbiol Infect. 2016 Jan;22(1):63.e1-63.e5. doi: 10.1016/j.cmi.2015.08.019. Epub 2015 Aug 29.

23.

First implementation of frozen, capsulized faecal microbiota transplantation for recurrent Clostridium difficile infection into clinical practice in Europe.

Tacke D, Wisplinghoff H, Kretzschmar A, Farowski F, Koehler P, Herweg J, Cornely OA, Vehreschild MJ.

Clin Microbiol Infect. 2015 Nov;21(11):e82-4. doi: 10.1016/j.cmi.2015.06.027. Epub 2015 Jul 8. No abstract available.

24.

Economic burden of Clostridium difficile associated diarrhoea: a cost-of-illness study from a German tertiary care hospital.

Heimann SM, Vehreschild JJ, Cornely OA, Wisplinghoff H, Hallek M, Goldbrunner R, Böttiger BW, Goeser T, Hölscher A, Baldus S, Müller F, Jazmati N, Wingen S, Franke B, Vehreschild MJ.

Infection. 2015 Dec;43(6):707-14. doi: 10.1007/s15010-015-0810-x. Epub 2015 Jun 30.

PMID:
26123227
25.

[Epidemiology and clinical features of Acinetobacter baumannii infections in humans].

Wisplinghoff H, Seifert H.

Berl Munch Tierarztl Wochenschr. 2014 Nov-Dec;127(11-12):447-57. German.

PMID:
25872254
26.

Our 2015 approach to invasive pulmonary aspergillosis.

Liss B, Vehreschild JJ, Bangard C, Maintz D, Frank K, Grönke S, Michels G, Hamprecht A, Wisplinghoff H, Markiefka B, Hekmat K, Vehreschild MJ, Cornely OA.

Mycoses. 2015 Jun;58(6):375-82. doi: 10.1111/myc.12319. Epub 2015 Mar 24. Review.

PMID:
25808916
27.

A cost and resource utilization analysis of micafungin bridging for hemato-oncological high-risk patients undergoing allogeneic stem cell transplantation.

Heimann SM, Vehreschild MJ, Cornely OA, Franke B, von Bergwelt-Baildon M, Wisplinghoff H, Kron F, Scheid C, Vehreschild JJ.

Eur J Haematol. 2015 Jun;94(6):526-31. doi: 10.1111/ejh.12466. Epub 2015 Feb 23.

PMID:
25310918
28.

Candidemia in the intensive care unit: analysis of direct treatment costs and clinical outcome in patients treated with echinocandins or fluconazole.

Heimann SM, Cornely OA, Wisplinghoff H, Kochanek M, Stippel D, Padosch SA, Langebartels G, Reuter H, Reiner M, Vierzig A, Seifert H, Vehreschild MJ, Glossmann J, Franke B, Vehreschild JJ.

Eur J Clin Microbiol Infect Dis. 2015 Feb;34(2):331-8. doi: 10.1007/s10096-014-2230-8. Epub 2014 Sep 12.

PMID:
25213718
29.

Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation: a 6-yr analysis from the cologne cohort for neutropenic patients.

Vehreschild MJ, von Bergwelt-Baildon M, Tran L, Shimabukuro-Vornhagen A, Wisplinghoff H, Bangard C, Cornely OA, Vehreschild JJ.

Eur J Haematol. 2014 Nov;93(5):400-6. doi: 10.1111/ejh.12368. Epub 2014 May 26.

PMID:
24798021
30.

Clostridium difficile infection in patients with acute myelogenous leukemia and in patients undergoing allogeneic stem cell transplantation: epidemiology and risk factor analysis.

Vehreschild MJ, Weitershagen D, Biehl LM, Tacke D, Waldschmidt D, Töx U, Wisplinghoff H, Von Bergwelt-Baildon M, Cornely OA, Vehreschild JJ.

Biol Blood Marrow Transplant. 2014 Jun;20(6):823-8. doi: 10.1016/j.bbmt.2014.02.022. Epub 2014 Mar 6.

31.

Prevalence and molecular characterization of azole resistance in Aspergillus spp. isolates from German cystic fibrosis patients.

Fischer J, van Koningsbruggen-Rietschel S, Rietschel E, Vehreschild MJ, Wisplinghoff H, Krönke M, Hamprecht A.

J Antimicrob Chemother. 2014 Jun;69(6):1533-6. doi: 10.1093/jac/dku009. Epub 2014 Jan 31.

PMID:
24486872
32.

Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities.

Wisplinghoff H, Ebbers J, Geurtz L, Stefanik D, Major Y, Edmond MB, Wenzel RP, Seifert H.

Int J Antimicrob Agents. 2014 Jan;43(1):78-81. doi: 10.1016/j.ijantimicag.2013.09.005. Epub 2013 Oct 12.

PMID:
24182454
33.

Carbapenem-Resistant Enterobacteriaceae: Laboratory Detection and Infection Control Practices.

Kruse EB, Aurbach U, Wisplinghoff H.

Curr Infect Dis Rep. 2013 Oct 12. [Epub ahead of print]

PMID:
24122401
34.

Prevalence of pharyngeal and rectal Chlamydia trachomatis and Neisseria gonorrhoeae infections among men who have sex with men in Germany.

Dudareva-Vizule S, Haar K, Sailer A, Wisplinghoff H, Wisplinghoff F, Marcus U; PARIS study group.

Sex Transm Infect. 2014 Feb;90(1):46-51. doi: 10.1136/sextrans-2012-050929. Epub 2013 Aug 6.

PMID:
23920398
35.

RIG-I detects triphosphorylated RNA of Listeria monocytogenes during infection in non-immune cells.

Hagmann CA, Herzner AM, Abdullah Z, Zillinger T, Jakobs C, Schuberth C, Coch C, Higgins PG, Wisplinghoff H, Barchet W, Hornung V, Hartmann G, Schlee M.

PLoS One. 2013 Apr 30;8(4):e62872. doi: 10.1371/journal.pone.0062872. Print 2013.

36.

Lymphogranuloma venereum in men screened for pharyngeal and rectal infection, Germany.

Haar K, Dudareva-Vizule S, Wisplinghoff H, Wisplinghoff F, Sailer A, Jansen K, Henrich B, Marcus U.

Emerg Infect Dis. 2013 Mar;19(3):488-92. doi: 10.3201/eid1903.121028.

37.

Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infection.

Ammerlaan HS, Harbarth S, Buiting AG, Crook DW, Fitzpatrick F, Hanberger H, Herwaldt LA, van Keulen PH, Kluytmans JA, Kola A, Kuchenbecker RS, Lingaas E, Meessen N, Morris-Downes MM, Pottinger JM, Rohner P, dos Santos RP, Seifert H, Wisplinghoff H, Ziesing S, Walker AS, Bonten MJ.

Clin Infect Dis. 2013 Mar;56(6):798-805. doi: 10.1093/cid/cis1006. Epub 2012 Dec 7.

38.

Molecular epidemiology of Acinetobacter baumannii and Acinetobacter nosocomialis in Germany over a 5-year period (2005-2009).

Schleicher X, Higgins PG, Wisplinghoff H, Körber-Irrgang B, Kresken M, Seifert H.

Clin Microbiol Infect. 2013 Aug;19(8):737-42. doi: 10.1111/1469-0691.12026. Epub 2012 Oct 3.

39.

Molecular epidemiology of Acinetobacter baumannii bloodstream isolates obtained in the United States from 1995 to 2004 using rep-PCR and multilocus sequence typing.

Higgins PG, Janssen K, Fresen MM, Wisplinghoff H, Seifert H.

J Clin Microbiol. 2012 Nov;50(11):3493-500. doi: 10.1128/JCM.01759-12. Epub 2012 Aug 15.

40.

Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies.

Liss BJ, Vehreschild JJ, Cornely OA, Hallek M, Fätkenheuer G, Wisplinghoff H, Seifert H, Vehreschild MJ.

Infection. 2012 Dec;40(6):613-9. doi: 10.1007/s15010-012-0269-y. Epub 2012 Jun 5.

PMID:
22665143
41.

Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States.

Wisplinghoff H, Paulus T, Lugenheim M, Stefanik D, Higgins PG, Edmond MB, Wenzel RP, Seifert H.

J Infect. 2012 Mar;64(3):282-90. doi: 10.1016/j.jinf.2011.12.008. Epub 2011 Dec 20.

PMID:
22209744
42.

Pandemic 2009 influenza A(H1N1) virus infection coinciding with invasive pulmonary aspergillosis in neutropenic patients.

Vehreschild JJ, Bröckelmann PJ, Bangard C, Verheyen J, Vehreschild MJ, Michels G, Wisplinghoff H, Cornely OA.

Epidemiol Infect. 2012 Oct;140(10):1848-52. doi: 10.1017/S0950268811002603. Epub 2011 Dec 8.

PMID:
22152763
43.

gyrB multiplex PCR to differentiate between Acinetobacter calcoaceticus and Acinetobacter genomic species 3.

Higgins PG, Lehmann M, Wisplinghoff H, Seifert H.

J Clin Microbiol. 2010 Dec;48(12):4592-4. doi: 10.1128/JCM.01765-10. Epub 2010 Sep 29.

44.

Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort.

Vehreschild JJ, Rüping MJ, Wisplinghoff H, Farowski F, Steinbach A, Sims R, Stollorz A, Kreuzer KA, Hallek M, Bangard C, Cornely OA.

J Antimicrob Chemother. 2010 Jul;65(7):1466-71. doi: 10.1093/jac/dkq121. Epub 2010 Apr 21.

PMID:
20410061
45.

Activity of the investigational fluoroquinolone finafloxacin against ciprofloxacin-sensitive and -resistant Acinetobacter baumannii isolates.

Higgins PG, Stubbings W, Wisplinghoff H, Seifert H.

Antimicrob Agents Chemother. 2010 Apr;54(4):1613-5. doi: 10.1128/AAC.01637-09. Epub 2010 Jan 25.

46.

Differential expression of ccrA in methicillin-resistant Staphylococcus aureus strains carrying staphylococcal cassette chromosome mec type II and IVa elements.

Higgins PG, Rosato AE, Seifert H, Archer GL, Wisplinghoff H.

Antimicrob Agents Chemother. 2009 Oct;53(10):4556-8. doi: 10.1128/AAC.00395-09. Epub 2009 Jul 13.

47.

Molecular epidemiology of clinical Acinetobacter baumannii and Acinetobacter genomic species 13TU isolates using a multilocus sequencing typing scheme.

Wisplinghoff H, Hippler C, Bartual SG, Haefs C, Stefanik D, Higgins PG, Seifert H.

Clin Microbiol Infect. 2008 Jul;14(7):708-15. doi: 10.1111/j.1469-0691.2008.02010.x.

48.

[Epidemiology, course and prognosis of Staphylococcus aureus bacteremia--Preliminary results from the INSTINCT (INvasive STaphylococcus aureus INfection CohorT) cohort].

Seifert H, Wisplinghoff H, Kaasch A, Achilles K, Langhorst A, Peyerl-Hoffmann G, Woehrmann A, Fätkenheuer G, Salzberger B, Kern WV.

Dtsch Med Wochenschr. 2008 Feb;133(8):340-5. doi: 10.1055/s-2008-1046715. German.

PMID:
18270913
49.

A PCR-based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU.

Higgins PG, Wisplinghoff H, Krut O, Seifert H.

Clin Microbiol Infect. 2007 Dec;13(12):1199-201. Epub 2007 Sep 10.

50.

Resistance to disinfectants in epidemiologically defined clinical isolates of Acinetobacter baumannii.

Wisplinghoff H, Schmitt R, Wöhrmann A, Stefanik D, Seifert H.

J Hosp Infect. 2007 Jun;66(2):174-81. Epub 2007 May 10.

PMID:
17498843

Supplemental Content

Loading ...
Support Center